Researchers say they've developed a surgical robot for removing brain tumors in children, and that it could also offer a less invasive, safer option for adult neurosurgery and other procedures. The trick is using hollow, nitinol robot arms to … [Read More...] about Two-armed surgical robot prototype targets pediatric brain tumors
Main Content
Featured
Today on Medical Tubing & Extrusion
- Two-armed surgical robot prototype targets pediatric brain tumors
- Zeus opens Minnesota catheter manufacturing facility
- Biosense Webster begins Omnypulse pulsed-field ablation trial
- CereVasc wins FDA IDE to expand eShunt trial
- Farapulse founder’s Field Medical raises $14M for next-gen cardiac ablation tech
Medical Tubing & Extrusion

Two-armed surgical robot prototype targets pediatric brain tumors
Researchers say they've developed a surgical robot for removing brain tumors in children, and that it could also offer a less invasive, safer option for adult neurosurgery and other procedures. The trick is using hollow, nitinol robot arms to … [Read More...] about Two-armed surgical robot prototype targets pediatric brain tumors

Zeus opens Minnesota catheter manufacturing facility
Zeus has opened its catheter manufacturing facility in Arden Hills, Minnesota, celebrating the new facility with a grand opening. The 75,600-ft² building is home to CathX Medical, which Zeus acquired 2021. The facility has advanced R&D lab and … [Read More...] about Zeus opens Minnesota catheter manufacturing facility

Biosense Webster begins Omnypulse pulsed-field ablation trial
By Sean Whooley
Johnson & Johnson's Biosense Webster today announced the first cases with its investigational Omnypulse catheter as part of the Omny-IRE clinical trial. The Omnypulse platform features the Omnypulse catheter and the Trupulse generator. … [Read More...] about Biosense Webster begins Omnypulse pulsed-field ablation trial

CereVasc wins FDA IDE to expand eShunt trial
By Sean Whooley
CereVasc announced today that the FDA approved an investigational device exemption (IDE) supplement for a study of its eShunt system. The FDA permitted the expansion of the study for patients with normal pressure hydrocephalus (NPH) to additional … [Read More...] about CereVasc wins FDA IDE to expand eShunt trial

Farapulse founder’s Field Medical raises $14M for next-gen cardiac ablation tech
By Sean Whooley
Field Medical announced today that it closed an oversubscribed seed round with investments reaching $14 million. Private investors led the funding for the Cardiff-by-the-Sea, California-based cardiac ablation technology developer. Multiple … [Read More...] about Farapulse founder’s Field Medical raises $14M for next-gen cardiac ablation tech

Medical nitinol processing: How NiTi is turned into wire, tubes and sheets for medical devices
Medical nitinol processing transforms raw nickel-titanium alloy into wire, coils, tubes and sheets for medical and dental device manufacturers. We previously covered nitinol's journey from the earth's crust through high-temperature melting … [Read More...] about Medical nitinol processing: How NiTi is turned into wire, tubes and sheets for medical devices

FDA approves LimFlow chronic limb-threatening ischemia treatment
By Sean Whooley
LimFlow announced today that the FDA approved its LimFlow System for treating chronic limb-threatening ischemia (CLTI). Approval enables the treatment to help those with CLTI with no other suitable endovascular or surgical treatment options … [Read More...] about FDA approves LimFlow chronic limb-threatening ischemia treatment